Marshall Hayward

Marshall Hayward is the Chief Scientific Officer at Jupiter Neurosciences, Inc. Between 2002-2013, Dr. Hayward served as Chief Scientific Officer at Effrx Pharmaceuticals where he was instrumental in all aspects of the development and approvals of the Binosto® product. He also served as Vice President of Business Development for Hurley Consulting Associates, LTD., a specialist pharmaceutical consulting firm, and was previously Director of New Business Development at Rhoda Pharmaceutical Ingredients. Dr. Hayward was also the Director and Vice President of Analgesics Research and Development at SmithKline Beecham (UK). He was a senior scientist in wound healing research and development at Johnson & Johnson. His pharmaceutical experience began at Ayerst Laboratories Research (later Wyeth), responsible for metabolic bone disease research. Dr. Hayward received a Ph.D. in Biochemistry from the University of Illinois at Urbana-Champaign and did postdoctoral work there in molecular biology. His undergraduate degree is a B.S. (Biochemistry with High Honor) from the Honors College of Michigan State University. In total, Dr. Hayward has over 30 years of industry R&D experience.